Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Parallel Group, 10-Week Placebo Controlled Fixed Dose Study of PD 0332334 and Paroxetine Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date06/23/08 → 06/22/09

Funding

  • Pfizer Incorporated: $19,824.40